| Trade name of the product: |
| Menveo |
| Pharmaceutical active ingredients: |
| Corynebacterium Diphtheriae CRM-197 ProteinMeningococcal Group A OligosaccharideMeningococcal Group C OligosaccharideMeningococcal Group W-135 OligosaccharideMeningococcal Group Y Oligosaccharide |
| Available forms, composition and doses of Menveo: |
| Injectable; Injection; Corynebacterium Diphtheriae CRM-197 Protein 47 mcg; Meningococcal Group A Oligosaccharide 10 mcg; Meningococcal Group C Oligosaccharide 5 mcg; Meningococcal Group W-135 Oligosaccharide 5 mcg; Meningococcal Group Y Oligosaccharide 5 mcg / 0.5 ml |
| Medical categories: |
| Human:Vaccines, antisera and immunologicals |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J07AH08 - Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen conjugated |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Where to buy Menveo brand or generic online: |
Buy Menveo online
|